424B3

Prospectus

Avalo Therapeutics, Inc. Filed 2017-11-07 Acc 0001628280-17-010988

Documents 1

424B3 Prospectus , cerc424b311062017.htm

Around this filing

Link to a passage

External

SEC EDGAR (opens in new tab)